Charles River Laboratories Hits Day Low of $165.60 Amid Price Pressure

Charles River Laboratories International, Inc. experienced a significant decline today, with the stock dropping by 9.23% as it reached an intraday low of USD 165.60. This performance starkly contrasts with the S&P 500, which saw a modest decrease of 0.41% on the same day. Over the past week, Charles River's stock has decreased by 5.2%, while the S&P 500 gained 0.95%. In terms of longer-term performance, the stock has faced challenges, with a year-to-date decline of 15.91%, compared to a 3.84% increase in the S&P 500. Over the past three years, Charles River has seen a decrease of 16.51%, while the broader market has surged by 71.97%. The company's one-year return of 0.45% is notably lower than the S&P 500's return of 14.11%. Financial metrics indicate a return on capital employed (ROCE) of 11.49%, with a concerning drop in net profit for the first half of the year, which fell by 37.49%. The company's market capitalization stands at USD 7,503 million, reflecting its small-cap status within the miscellaneous industry.